Replies to post #70886 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

Doesn't really matter much whether a milestone payment comes in this quarter or next. It is a receivable that will be on the balance sheet as a current asset in the next 10Q either way.

[mortmann]

Molly isn't getting paid a boatload of cash to sit on an Invoice that is an A/R. If its me, its ready to send out immediately on completion of the terms. The question is whether any $$ is due. As for timeliness, net 45 as of today we are at July 21 for payment. July 31 is EoQ3. Despite contract language, big companies, in my experience anyway, a/p policy is governed by their own controls and schedules. The variables are legion, but after being in the system and knowing exactly what is required for a valid Inv, its mostly how close our a/r is with their a/p staff. Most Cos with a decent relationship with suppliers are in the 45-60 net range. So it is very possible any a/r will remain in this Q that way unless a check is deposited. Again, we know AMGN is good for it, its about whether they're contractually obligated at this time.

[hdwrsft]

I hope a key decision maker gets wind of the milestone payment amount and due date, then turns around and says,

"Let's just buy 'em...why wait? Did you see their current valuation? It may not be that low if the results demonstrate promise.."

Could happen. We're dirt cheap...and then some.